EMERGING AND RE-EMERGING INFECTIOUS DISEASES AND BLOOD PRODUCT SAFETY

Author:

A. Furuta Rika1

Affiliation:

1. Infectious Disease Research Department, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Reference37 articles.

1. 1) Updated Information for Blood Establishments Regarding the COVID-19 Pandemic and Blood Donation, 2022/1/11. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/updated-information-blood-establishments-regarding-covid-19-pandemic-and-blood-donation (2023/7 accessed).

2. 2) Overview of Testing for SARS-CoV-2, the virus that causes COVID-19. Updated May 11, 2023. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html (2023/7 accessed).

3. 3) 国立感染症研究所病原体検出マニュアル 新型コロナウイルス感染症. https://www.niid.go.jp/niid/ja/lab-manual-m/9559-2020-04-14-10-09-54.html (2023年7月現在).

4. 4) Kumari M, Lu R, Li M, et al: A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J Biomed Sci, 29: 68, 2022.

5. 5) Hillary VE, Ceasar SA: An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines. Heliyon, 9: e13952, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3